| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2462416C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2446112C A method for regulating immune function in primates using the foxp3 protein |
| 04/26/2011 | CA2420410C Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/26/2011 | CA2337988C Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2011 | CA2337971C Novel anti-diabetic peptides |
| 04/26/2011 | CA2319093C Sea cucumber carotenoid lipid fraction products and methods of use |
| 04/21/2011 | WO2011047350A2 Emesis treatment |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011046395A2 Preventing or treating periodontal diseases by herbal extract |
| 04/21/2011 | WO2011046221A1 INTERFERON-α MODULATOR |
| 04/21/2011 | WO2011046204A1 Marker associated with non-alcoholic steatohepatitis |
| 04/21/2011 | WO2011045823A1 Composition based on muscari comosum and aloe vera barbadensis |
| 04/21/2011 | WO2011044638A1 Method of treatment of liver disease |
| 04/21/2011 | WO2011014973A3 Conformationally constrained, fully synthetic macrocyclic compounds |
| 04/21/2011 | WO2011012896A3 Spirocyclic amide derivatives |
| 04/21/2011 | WO2010150984A3 Amorphous adefovir dipivoxil solid dispersion with improved stability, and method for preparing same |
| 04/21/2011 | WO2010147309A3 Pharmaceutical composition for preventing or treating inflammatory gastrointestinal disease comprising patchouli extract |
| 04/21/2011 | WO2010138794A3 Regulation of sodium channels by plunc proteins |
| 04/21/2011 | WO2010138519A9 Use of adsorbent carbon microspheres for the treatment of pruritus |
| 04/21/2011 | WO2010120750A3 Amorphous esomeprazole magnesium |
| 04/21/2011 | US20110092674 Non-Functional P2X7 Receptor |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092592 Diagnosis and treatment of hepatic disorder |
| 04/21/2011 | US20110092589 Treatment of Inflammatory Conditions and Diseases with Metal-Thiols |
| 04/21/2011 | US20110092588 Lactone formulations and method of use |
| 04/21/2011 | US20110092583 Oral Dosage Form Of Tetrahydrocannabinol And A Method Of Avoiding And/Or Suppressing Hepatic First Pass Metabolism Via Targeted Chylomicron/Lipoprotein Delivery |
| 04/21/2011 | US20110092579 Solubilized formulation of docetaxel |
| 04/21/2011 | US20110092575 Sirna of human osteopontin |
| 04/21/2011 | US20110092571 Compositions and methods for sirna inhibition of icam-1 |
| 04/21/2011 | US20110092561 Benzoisoindole derivatives for the treatment of pain |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092516 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases |
| 04/21/2011 | US20110092512 New hsl inhibitors useful in the treatment of diabetes |
| 04/21/2011 | US20110092506 Trisubstituted amine compound |
| 04/21/2011 | US20110092493 Dose-controlled transdermal promethazine compositions and methods of use |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092459 Alpha helix mimetics and methods relating thereto |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091578 Method of stimulating tissue healing |
| 04/21/2011 | US20110091566 Controlled release pharmaceutical compositions |
| 04/21/2011 | US20110091563 Orally-disintergrating solid preparation |
| 04/21/2011 | US20110091542 Baclofen and r-baclofen gastroretentive drug delivery systems |
| 04/21/2011 | US20110091536 Compositions comprising euphorbia prostrata and process of preparation thereof |
| 04/21/2011 | US20110091515 Drug-eluting medical devices |
| 04/21/2011 | US20110091475 Anti-Human Interleukin-20 Antibodies |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091461 Binding domain-immunoglobulin fusion proteins |
| 04/21/2011 | US20110091459 Imidazole modulators of muscarinic acetylcholine receptor m3 |
| 04/21/2011 | US20110091450 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | US20110091445 Modulation of intestinal flora of hiv patients |
| 04/21/2011 | US20110091442 Novel compositions for preventing and/or treating lysosomal storage disorders |
| 04/21/2011 | US20110091434 Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucosyltransferase |
| 04/21/2011 | US20110091424 Oral dosage composition |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/21/2011 | US20110091415 Hydroxyethyl Starch-Containing Polypeptide Compositions |
| 04/21/2011 | US20110091395 Extract of phaleria macrocarpa as an antineoplastic, anti-inflammatory and antiangiogenic agent |
| 04/21/2011 | US20110091392 Compositions for the treatment and prevention of infections of the oral cavity |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | DE102009049332A1 Medicinal substance, useful e.g. for treating hemorrhoidal disease, comprises lactulose, which is used for supplying nutrients to the mucous membrane of the colon, pH adjustment and stabilizing the physiological intestinal flora rectally |
| 04/21/2011 | CA2777823A1 Antibody therapeutics with local activity in the digestive tract |
| 04/21/2011 | CA2777358A1 Emesis treatment |
| 04/21/2011 | CA2777013A1 Marker associated with non-alcoholic steatohepatitis |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311864A1 Recombinant protein-s composition |
| 04/20/2011 | EP2311847A1 Composition containing stable vitamin B6 derivative |
| 04/20/2011 | EP2311818A1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug |
| 04/20/2011 | EP2311486A1 GLP-2 for use in intestine and muscle recovery |
| 04/20/2011 | EP2311476A2 Cancer cell growth inhibition by black bean (phaseolus vulgaris l) extracts |
| 04/20/2011 | EP2311453A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2311448A1 Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite |
| 04/20/2011 | EP2310005A2 Treatment of inflammatory conditions with isothiocyanates |
| 04/20/2011 | EP1933833B1 Therapy for the treatment of overactive bladder |
| 04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
| 04/20/2011 | EP1449534B1 Ganoderma atrum extract as matrix metalloprotease inhibitor |
| 04/20/2011 | EP1359978B1 Devices for use in performing pulmonary procedures |
| 04/20/2011 | CN201798926U Oral granule capable of protecting livers |
| 04/20/2011 | CN201798394U Traditional chinese medicine health preserving pillow |
| 04/20/2011 | CN1935131B Pharmaceutical use of 1 beta-hydroxy ilexolic acid for inhibiting hepatitis virus |
| 04/20/2011 | CN1930282B Novel lactic acid bacterium |
| 04/20/2011 | CN1883604B Detection method of compound preparation of red sage root and cape jasmine for treating acute and chronic hepatitis |
| 04/20/2011 | CN1882353B Sialogogue and oral composition and food composition containing same |
| 04/20/2011 | CN1876040B Detection method of pharmaceutical composition for treating hepatitis |
| 04/20/2011 | CN1709341B Medicinal composition for nourishing qi to invigorate spleen, and its preparing method and use |
| 04/20/2011 | CN1698620B Cucurbitacin emulsion capable of filtering out and eliminating bacteria and preparation method thereof |
| 04/20/2011 | CN102026994A Crystal of benzimidazole compound |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102026630A Film-shaped preparation comprising oily substances for oral administration |
| 04/20/2011 | CN102026617A Sweet containing algae for the prevention of oro-dental infections |